Arynta is a medicine used to treat attention deficit hyperactivity disorder (ADHD). ADHD is a common condition in children, and it also affects adults. ADHD affects how you pay attention, focus, and ...
Active ingredient: Guanfacine (as HCl) 1 mg, 2 mg, 3 mg, 4 mg; extended-release tabs. Indication: Attention- deficit hyperactivity disorder (ADHD) in patients aged 6-17 years. Clinical trials: The ...
CTx-1301 is designed to deliver 3 separate releases of medication at different times and in different ratios. Topline data were announced from a phase 3 trial evaluating CTx-1301 for the treatment of ...
Please provide your email address to receive an email when new articles are posted on . Non-superiority of the treatments was observed at 4 weeks and again at 6 months. Adverse events among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results